Peroxidasin is essential for eye development in the mouse

Human Molecular Genetics

Volumn 23, Issue 21, 2014, Pages 5597-5614

  Yan, Xiaohe ^a,f   Sabrautzki, Sibylle ^b   Horsch, Marion ^b,c   Fuchs, Helmut ^b,c   Gailus Durner, Valerie ^b,c   Beckers, Johannes ^b,c,d,e   de Angelis, Martin Hrabě ^b,c,d,e   Graw, Jochen ^a,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Institute of Experimental Genetics   (Germany)

^c Institute of Experimental Genetics and the German Mouse Clinic   (Germany)

^d GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYSTEINE; ETHYLNITROSOUREA; GAMMA CRYSTALLIN; PEROXIDASE; TRANSCRIPTION FACTOR PAX6; PEROXIDASIN; SCLEROPROTEIN;

ADHESION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ANTERIOR SEGMENT DYSGENESIS; ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; EMBRYO DEVELOPMENT; EYE DEVELOPMENT; EYE INFLAMMATION; EYE MALFORMATION; FOXE3 GENE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLAUCOMA; LENS CAPSULE; LENS EPITHELIUM; MALE; MICROPHTHALMIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PAX6 GENE; PEROXIDASIN GENE; PHENOTYPE; RETINA MALFORMATION; SEQUENCE ANALYSIS; STOP CODON; TRANSCRIPTOMICS; ANIMAL; CELL ADHESION; EMBRYOLOGY; EXTRACELLULAR MATRIX; EYE; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENETICS; GENOTYPE; LENS; METABOLISM; MUTATION; OPTIC DISK; ORGANOGENESIS; PATHOLOGY; RETINA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CELL ADHESION; CELL PROLIFERATION; DNA MUTATIONAL ANALYSIS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; EYE; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; GENOTYPE; LENS, CRYSTALLINE; MALE; MICE; MUTATION; OPTIC DISK; ORGANOGENESIS; PEROXIDASE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINA;

EID: 84908590724     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu274     Document Type: Article

References (61)

1. Shigeyasu, C., Yamada, M., Mizuno, Y., Yokoi, T., Nishina, S. and Azuma, N. (2012) Clinical features of anterior segment dysgenesis associated with congenital corneal opacities. Cornea, 31, 293-298.
2. Reis, L.M. and Semina, E.V. (2011) Genetics of anterior segment dysgenesis disorders. Curr. Opin. Ophthalmol., 22, 314-324.
3. Sibon, I., Coupry, I., Menegon, P., Bouchet, J.P., Gorry, P., Burgelin, I., Calvas, P., Orignac, I., Dousset, V., Lacombe, D. et al. (2007) COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. Ann. Neurol., 62, 177-184.
4. Rødahl, E., Knappskog, P.M., Majewski, J., Johansson, S., Telstad, W., Kråkenes, J. and Boman, H. (2013) Variants of anterior segment dysgenesis and cerebral involvement in a large family with a novel COL4A1 mutation. Am. J. Ophthalmol., 155, 946-953.
5. Hopfer, U., Fukai, N., Hopfer, H., Wolf, G., Joyce, N., Li, E. and Olsen, B.R. (2005) Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. FASEB J., 19, 1232-1244.
6. Khan, K., Rudkin, A., Parry, D.A., Burdon, K.P., McKibbin, M., Logan, C.V., Abdelhamed, Z.I., Muecke, J.S., Fernandez-Fuentes, N., Laurie, K.J. et al. (2011) Homozygous mutations in PXDN cause congenital cataract, corneal opacity, and developmental glaucoma. Am. J. Hum. Genet., 89, 464-473.
7. Tindall, A.J., Pownall, M.E., Morris, I.D. and Isaacs, H.V. (2005) Xenopus tropicalis peroxidasin gene is expressed within the developing neural tube and pronephric kidney. Dev. Dyn., 232, 377-384.
8. Homma, S., Shimada, T., Hikake, T. and Yaginuma, H. (2009) Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expr. Patterns, 9, 1-26.
9. Horikoshi, N., Cong, J., Kley, N. and Shenk, T. (1999) Isolation of differentially expressed cDNAs from p53-dependent apoptotic cells: activation of the human homologue of the Drosophila peroxidasin gene. Biochem. Biophys. Res. Commun., 261, 864-869.
10. Mitchell, M.S., Kan-Mitchell, J., Minev, B., Edman, C. and Deans, R.J. (2000)A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. Cancer Res., 60, 6448-6456.
11. Cheng, G., Salerno, J.C., Cao, Z., Pagano, P.J. and Lambeth, J.D. (2008) Identification and characterization of VPO1, a new animal heme-containing peroxidase. Free Radic. Biol. Med., 45, 1682-1694.
12. Nelson, R.E., Fessler, L.I., Takagi, Y., Blumberg, B., Keene, D.R., Olson, P.F., Parker, C.G. and Fessler, J.H. (1994) Peroxidasin: a novel enzyme-matrix protein of Drosophila development. EMBO J., 13, 3438-3447.
13. Péterfi, Z., Donkó, A., Orient, A., Sum, A., Prókai, A., Molnár, B., Veréb, Z., Rajnavölgyi, E., Kovács, K.J.,Müller, V., Szabó, A.J. and Geiszt, M. (2009) Peroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidney. Am. J. Pathol., 175, 725-735.
14. Gotenstein, J.R., Swale, R.E., Fukuda, T., Wu, Z., Giurumescu, C.A., Goncharov, A., Jin, Y. and Chisholm, A.D. (2010) The C. elegans peroxidasin PXN-2 is essential for embryonic morphogenesis and inhibits adult axon regeneration. Development, 137, 3603-3613.
15. Bhave, G., Cummings, C.F., Vanacore, R.M., Kumagai-Cresse, C., Ero-Tolliver, I.A., Rafi, M., Kang, J.S., Pedchenko, V., Fessler, L.I., Fessler, J.H. and Hudson, B.G. (2012) Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis. Nat. Chem. Biol., 8, 784-790.
16. Li, H., Cao, Z., Moore, D.R., Jackson, P.L., Barnes, S., Lambeth, J.D., Thannickal, V.J. and Cheng, G. (2012) Microbicidal activity of vascular peroxidase 1 in human plasma via generation of hypochlorous acid. Infect. Immun., 80, 2528-2537.
17. Bai, Y.P., Hu, C.P., Yuan, Q., Peng, J., Shi, R.Z., Yang, T.L., Cao, Z.H., Li, Y.J., Cheng, G. and Zhang, G.G. (2011) Role of VPO1, a newly identified heme-containing peroxidase, in ox-LDL induced endothelial cell apoptosis. Free Radic. Biol. Med., 51, 1492-1500.
18. Ma, Q.L., Zhang, G.G. and Peng, J. (2013) Vascular peroxidase 1: a novel enzyme in promoting oxidative stress in cardiovascular system. Trends Cardiovasc. Med., 23, 179-183.
19. Hrabé de Angelis, M., Flaswinkel, H., Fuchs, H., Rathkolb, B., Soewarto, D., Marschall, S., Heffner, S., Pargent, W., Wuensch, K., Jung, M. et al. (2000) Genome-wide, large-scale production of mutant mice byENUmutagenesis. Nat, Genet., 25, 444-447.
20. Fuchs, H., Gailus-Durner, V., Neschen, S., Adler, T., Afonso, L.C., Aguilar-Pimentel, J.A., Becker, L., Bohla, A., Calzada-Wack, J., Cohrs, C. et al. (2012) Innovations in phenotyping of mouse models in the German Mouse Clinic. Mamm. Genome, 23, 611-622.
21. Blixt, A., Landgren, H., Johansson, B.R. and Carlsson, P. (2007) Foxe3 is required for morphogenesis and differentiation of the anterior segment of the eye and is sensitive to Pax6 gene dosage. Dev. Biol., 302, 218-229.
22. Murer-Orlando, M., Paterson, R.C., Lok, S., Tsui, L.C. and Breitman, M.L. (1987) Differential regulation of gamma-crystallin genes during mouse lens development. Dev Biol., 119, 260-267.
23. Lovicu, F.J. and McAvoy, J.W. (2001) FGF-induced lens cell proliferation anddifferentiationisdependentonMAPK(ERK1/2) signalling.Development, 128, 5075-5084.
24. Gehring, W.J. (1996) The master control gene for morphogenesis and evolution of the eye. Genes Cells, 1, 11-15.
25. Graw, J. (2010) Eye development. Curr. Top. Dev. Biol., 90C, 343-386.
26. Shaham, O., Menuchin, Y., Farhy, C. and Ashery-Padan, R. (2012) Pax6: a multi-level regulator of ocular development. Prog. Retin. Eye Res., 31, 351-376.
27. Blixt, A., Mahlapuu, M., Aitola, M., Pelto-Huikko, M., Enerbäck, S. and Carlsson, P. (2000) A forkhead gene, FoxE3, is essential for lens epithelial proliferation and closure of the lens vesicle. Genes Dev., 14, 245-254.
28. Medina-Martinez, O., Brownell, I., Amaya-Manzanares, F., Hu, Q., Behringer, R.R. and Jamrich, M. (2005) Severe defects in proliferation and differentiation of lens cells in Foxe3 null mice. Mol. Cell. Biol., 25, 8854-8863.
29. Ahmad, N., Aslam, M., Muenster, D., Horsch, M., Khan, M.A., Carlsson, P., Beckers, J. and Graw, J. (2013) Pitx3 directly regulates Foxe3 during early lens development. Int. J. Dev. Biol., 57, 741-751.
30. Kelley, P.B., Sado, Y. and Duncan, M.K. (2002) Collagen IV in the developing lens capsule. Matrix Biol., 21, 415-423.
31. Schedl, A., Ross, A., Lee, M., Engelkamp, D., Rashbass, P., van Heyningen, V. and Hastie, N.D. (1996) Influence of PAX6gene dosage on development: overexpression causes severe eye abnormalities. Cell, 86, 71-82.
32. Dora', N., Ou, J., Kucerova, R., Parisi, I., West, J.D. and Collinson, J.M. (2008) PAX6 dosage effects on corneal development, growth, and wound healing. Dev. Dyn., 237, 1295-1306.
33. Davis, J. and Piatigorsky, J. (2011) Overexpression of Pax6 in mouse cornea directly alters corneal epithelial cells: changes in immune function, vascularization, and differentiation. Invest. Ophthalmol. Vis. Sci., 52, 4158- 4168.
34. Manuel, M., Pratt, T., Liu, M., Jeffery, G. and Price, D.J. (2008) Overexpression of Pax6 results in microphthalmia, retinal dysplasia and defective retinal ganglion cell axon guidance. BMC Dev. Biol., 8, 59. doi: 10.1186/1471-213X-8-59.
35. Hettmann, T., Barton, K. and Leiden, J.M. (2000) Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor. Dev. Biol., 222, 110-123.
36. Medina-Martinez, O. and Jamrich, M. (2007) Foxe view of lens development and disease. Development, 134, 1455-1463.
37. Tholozan, F.M., Sanderson, J.M. and Quinlan, R.A. (2007) Focus on molecules: FoxE3. Exp. Eye Res., 84, 799-800.
38. Sarthy, V. (1993) Collagen IVmRNAexpression during development of the mouseretina: an in situ hybridization study. Invest. Ophthalmol. Vis. Sci., 34, 145-152.
39. Halfter, W., Dong, S., Schurer, B., Ring, C., Cole, G.J. and Eller, A. (2005) Embryonic synthesis of the inner limiting membrane and vitreous body. Invest. Ophthalmol. Vis. Sci., 46, 2202-2209.
40. van Agtmael, T., Schlötzer-Schrehardt, U., McKie, L., Brownstein, D.G., Lee, A.W., Cross, S.H., Sado, Y., Mullins, J.J., Pöschl, E. and Jackson, I.J. (2005) Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Hum. Mol. Genet., 14, 3161-3168.
41. Favor, J., Gloeckner, C.J., Janik, D., Klempt, M., Neuhäuser-Klaus, A., Pretsch, W., Schmahl, W. and Quintanilla-Fend, L. (2007) Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: an extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles. Genetics, 175, 725-736.
42. Gould, D.B., Marchant, J.K., Savinova, O.V., Smith, R.S. and John, S.W. (2007) Col4a1 mutation causes endoplasmic reticulum stress and genetically modifiable ocular dysgenesis. Hum. Mol. Genet., 16, 798-807.
43. Kuo, D.S., Labelle-Dumais, C., Mao, M., Jeanne, M., Kauffman, W.B., Allen, J., Favor, J. and Gould, D.B. (2014) Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations.Hum. Mol. Genet., 23, 1709-1722.
44. Gould, D.B., Phalan, F.C., Breedveld, G.J., van Mil, S.E., Smith, R.S., Schimenti, J.C., Aguglia, U., van der Knaap, M.S., Heutink, P. and John, S.W. (2005) Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science, 308, 1167-1171.
45. Gould, D.B., Phalan, F.C., van Mil, S.E., Sundberg, J.P., Vahedi, K., Massin, P., Bousser, M.G., Heutink, P., Miner, J.H., Tournier-Lasserve, E. and John, S.W. (2006) Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N. Engl. J. Med., 354, 1489-1496.
46. Weng, Y.C., Sonni, A., Labelle-Dumais, C., de Leau, M., Kauffman, W.B., Jeanne, M., Biffi, A., Greenberg, S.M., Rosand, J. and Gould, D.B. (2012) COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann. Neurol., 71, 470-477.
47. Jeanne, M., Labelle-Dumais, C., Jorgensen, J., Kauffman, W.B., Mancini, G.M., Favor, J., Valant, V., Greenberg, S.M., Rosand, J. and Gould, D.B. (2012) COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am. J. Hum. Genet., 90, 91-101.
48. Epstein, J.A. (1996) Pax3, neural crest and cardiovascular development. Trends Cardiovasc. Med., 6, 255-260.
49. Graw, J. (2010) Eye development. Curr. Top. Dev. Biol., 90, 343-386.
50. Chang, M.S. and Chiou, G.C. (1989) Prevention of lens protein-induced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors. J. Ocul. Pharmacol., 5, 353-360.
51. Xiao, J., Wang, Y., Wu, S., Li, J. and Zhang, S. (1992) Inhibitory effect of tetrandrine on lens proteins-induced ocular inflammation in rabbits. J. Ocul. Pharmacol., 8, 309-315.
52. Quigley, H.A. (2011) Glaucoma. Lancet, 377, 1367-1377.
53. Ehling, U.H., Charles, D.J., Favor, J., Graw, J., Kratochvilova, J., Neuhäuser-Klaus, A. and Pretsch, W. (1985) Induction of gene mutations in mice: the multiple endpoint approach. Mutat. Res., 150, 393-401.
54. Klaften, M. and Hrabé de Angelis, M. (2005)ARTS:a web-based tool for the set-up of high-throughput genome-wide mapping panels for the SNP genotyping of mouse mutants. Nucleic Acids Res., 33, W496-W500.
55. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
56. Graw, J., Löster, J., Puk, O., Münster, D., Haubst, N., Soewarto, D., Fuchs, H., Meyer, B., Nürnberg, P., Pretsch, W. et al. (2005) Three novel Pax6 alleles in the mouse leading to the same small-eye phenotype caused by different consequences at target promotors. Invest. Ophthalmol. Vis. Sci., 46, 4671-4683.
57. Kugler, J.E., Horsch, M., Huang, D., Furusawa, T.,Rochman,M., Garrett, L., Becker, L., Bohla, A., Hölter, S.M., Prehn, C. et al. (2013) High mobility groupNproteins modulate the fidelity of the cellular transcriptional profile in a tissue- and variant-specific manner. J. Biol. Chem., 288, 16690-16703.
58. Saeed, A.I., Bhagabati, N.K., Braisted, J.C., Liang, W., Sharov, V., Howe, E.A., Li, J., Thiagarajan, M., White, J.A. and Quackenbush, J. (2006) TM4 microarray software suite. Methods Enzymol., 411, 134-193.
59. Tusher, V.G., Tibshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
60. Horsch, M., Schädler, S., Gailus-Durner, V., Fuchs, H., Meyer, H., de Angelis, M.H. and Beckers, J. (2008) Systematic gene expression profiling of mouse model series reveals coexpressed genes. Proteomics, 8, 1248- 1256.
61. Edgar, R., Domrachev,M.and Lash, A.E. (2002)GeneExpression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.